Is It Time to Sell?

You are receiving this as part of your free subscription to Cannabis Profits Daily. To remove your email from this list, unsubscribe here.

Saturday, March 30, 2018 Q&A: Can You Pay for CBD with a Credit Card? By Greg Miller Welcome to another edition of our member Q&A. It was another exciting week, with a new trade for our Cannabis Insider's Report members, Walgreens' announcement that it will follow CVS in offering CBD products at its stores (I'll have more on that early next week), and a special House committee approval of a banking bill. That bill, the SAFE Banking Act, will be the first federal cannabis reform measure to see the House floor, marking a major turning point in American politics. A bill of this magnitude obviously has major implications for the cannabis industry, so I was happy to see our members thinking about how it will impact our investments. Here's a question Gus had about the bill... Gus M. asks: "Do we or have we identified the stocks that have to do with banking? Before the 'Banking Bill' is approved?" Excellent question, Gus. We have identified such a stock - of a sort. I'm not putting pure-play banking stocks in the Cannabis Investor's Report model portfolio because even the best cannabis banks won't grow at the rate of pure-play cannabis stocks, but last week I shared the story of Severn Bancorp (Nasdaq: SVBI) with our members. Severn appears to be the only publicly traded bank taking on cannabis customers in any real way. Looking forward, it's impossible to predict the winners among banks when the banking bill passes because most banks have not announced their plans. Wells Fargo has said that it will not enter the cannabis banking market even after that banking bill passes - it's going to wait until full federal legalization. I suspect most of the big national banks will come to the same conclusion. Regional banks will be the winners here, but I don't know which ones. I do have a friend, Tim Melvin, who follows the banking industry very closely. I've asked him to let me know when there's a standout, and when that company appears, I'll share it with you just as I did with Severn Bank. You can read my report on Severn by clicking here. Of course, banking wasn't the only news our members had questions about. Elroy J. wants to know: "How does CVS plan to accept payment from CBD sales? Is it legal to use credit or debit card?" Thanks for the question, Elroy. While CBD companies may have trouble securing financing from banks, they do not have the problems with deposits that THC-cannabis companies do. CVS can take a credit card payment for its CBD products just as easily as it can for shampoo. That's true of other CBD retailers, too. A company called Green Growth Brands (CSE: GGB, OTC: GGBXF) intends to put CBD kiosks in 600 malls across the United States. Every one of them will accept any major credit card. But let's turn our eyes to some recent market volatility. Othman H. says: "I bought cannabis stocks, some of which went down, especially on last Friday. Should I sell some and buy another? I need your guidance. Thank you in advance." Othman, I understand your concern - I've been there. Holding a stock when the market is falling is among the toughest disciplines an investor can acquire. For long-term investors, it's also one of the most important ones. For our members of Cannabis Investor's Report and The Cannabis IPO Insider, I give suggestions not only on which stocks to buy, but when to sell, too. But even those are general guidelines. I don't give individualized investing advice because each individual is different, and I don't know everyone's circumstances. So if I suggest selling a stock to take some profits and some members decide to hold on to it, that's perfectly fine! Likewise, if some event in someone's life means they have to sell a stock before I recommend selling it, that's OK too. I will say this: As cannabis investors, we have the clearest roadmap to profits I've ever seen in over 30 years in the investment business. We know there will be bumps on the road, but we also know where the road is going - to the top of the mountain. So as long as you've done your homework and bought the stock of a good company and it remains a good company, it's probably best to hold on to it during the bumps with an eye on that mountain's summit. We're thrilled to take that road with you. Greg Miller Executive Director, National Institute for Cannabis Investors We Just Pocketed a 100%+ Win, Now We're Giving You a Chance at the Next One For weeks, you've heard about the amazing profit potential lurking in cannabis IPOs. But members of The Cannabis IPO Insider are feeling the effects for themselves. Recently, members who followed our advice doubled their money on one of our flagship trades, lining their pockets with a cool 100%+ gain. But that's just the start. As we speak, we're not only gearing up to profit from the next double- or triple-digit gain, we've also go our eyes on our next IPO targets. And today, I'm inviting you to get in on the action before we strike. All you have to do is click here to learn more. What separates millionaire pot stock investors from the pack If you want a shot to get even richer from America's next trillion-dollar transformation, you need to know about the ULTIMATE pot stock investing tool. Our comprehensive cannabis database contains protected information on every publicly traded cannabis company on the market, future IPOs, and numerous front-runners and startups. We call it "The Vault" - and you can see how it works right here. See How to Conquer America's Most Controversial - And Most Lucrative - Industry Everyone knows that cannabis offers a chance to lock in a ground-floor opportunity for huge profits, with legal sales expected to skyrocket from $10 billion in 2017 to $24.5 billion by 2021. And one of the most exciting aspects of the future $24.5 billion market is there will be a flurry of marijuana IPOs. And today, we want to show average folks living in the United States how they can become millionaires from this little-understood investing phenomenon. Just click here to learn more. Not all stocks are created equal (especially in this corner of the market) Cannabis gained a solid win in the midterm elections - and this historic outpouring of support could easily trigger a wave of opportunity for savvy investors. But if you're not careful, you could fall into this common trap... You are receiving this e-mail at its028@gmail.com, as a part of your subscription. Remove your email from this list: Unsubscribe © 2019 The National Institute for Cannabis Investors All Rights Reserved The National Institute for Cannabis Investors | 1125 N Charles Street | Baltimore, MD 21201 Toll Free: 866.260.0361; International: 410.777.8270 Contact Customer Service Website: https://nicinvestors.com Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your financial adviser and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. This information may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The National Institute for Cannabis Investors, 1125 N Charles Street, Baltimore, MD 21201. Privacy Policy | Terms & Conditions